Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Adenocarcinoma × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 6 Neoplasms 6 Cancer Pain 6 Pain, Intractable 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Vesico-Ureteral Reflux 1 Ureteral Neoplasms 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pain, Postoperative 1 Nephrolithiasis 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Mucositis 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Oxaliplatin 8 Fluorouracil 6 Docetaxel 6 Paclitaxel 5 Leucovorin 5 Gemcitabine 5 Capecitabine 5 zolbetuximab 4 Cisplatin 4 Ramucirumab 3 Pemetrexed 3 Drug Therapy 3 Carboplatin 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 regorafenib 2 pembrolizumab 2 Vinorelbine 2 Surgical Procedures, Operative 2 Nivolumab 2 Neoadjuvant Therapy 2 Cyclophosphamide 2 Chemoradiotherapy 2 Bevacizumab 2 Afatinib 2 vandetanib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tislelizumab 1 pralsetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05325164 2022-12-05

METHADOPT

Ottawa Hospital Research Institute

Phase 3 Withdrawn

Cancer Pain, Adenocarcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡